Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 42

Results For "CRE"

4745 News Found

Dabur profit jumps 16% as FMCG growth gains pace
News | May 08, 2026

Dabur profit jumps 16% as FMCG growth gains pace

Hair care & quick commerce shine


Vijaya Diagnostic Q4FY26 revenue jumps 27%, EBITDA margin expands to 43.5%
Healthcare | May 08, 2026

Vijaya Diagnostic Q4FY26 revenue jumps 27%, EBITDA margin expands to 43.5%

With robust FY26 growth, plans AI-led diagnostics and genomic testing expansion


Cirena licenses Agilent RNA purification tech to unlock high-purity long RNA for genome editing
Technology | May 08, 2026

Cirena licenses Agilent RNA purification tech to unlock high-purity long RNA for genome editing

The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides


Industrial AI takes center stage at ARC Industry Leadership India Forum 2026
Supply Chain | May 08, 2026

Industrial AI takes center stage at ARC Industry Leadership India Forum 2026

The event will bring together industrial leaders, technology providers, and policymakers to discuss real-world Industrial AI applications in Bangalore


Illumina showcases multi-omics potential to advance precision medicine in India
Biopharma | May 08, 2026

Illumina showcases multi-omics potential to advance precision medicine in India

The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru


Yashoda Medicity unveils specialised thalassemia care centre in Uttar Pradesh
Hospitals | May 08, 2026

Yashoda Medicity unveils specialised thalassemia care centre in Uttar Pradesh

The facility combines advanced diagnostics, bone marrow transplant evaluation, prenatal awareness, and multidisciplinary support services


Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics
News | May 07, 2026

Bayer strikes $2.45 billion deal for breakthrough blindness drug developer Perfuse Therapeutics

The acquisition gives Bayer full rights to PER-001, an experimental therapy now in Phase II clinical trials for Glaucoma and Diabetic Retinopathy


Free HLA typing for children with thalassaemia launched in India
Healthcare | May 07, 2026

Free HLA typing for children with thalassaemia launched in India

The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia


Eli Lilly unveils $4.5 bn Indiana expansion
News | May 07, 2026

Eli Lilly unveils $4.5 bn Indiana expansion

The investment will upgrade and expand production capabilities at Lilly Lebanon API and Lilly Lebanon Advanced Therapies


Ajanta Pharma Q4 FY26 revenue surges 21% to Rs. 1,422 Crore; PAT climbs 18%
News | May 06, 2026

Ajanta Pharma Q4 FY26 revenue surges 21% to Rs. 1,422 Crore; PAT climbs 18%

FY26 revenue rises 17% to Rs. 5,453 crore as US generics business jumps 49% and adjusted EBITDA margin improves to 26% for the quarter